Overview

Description

  • NatureRecombinant
  • SourceEscherichia coli
  • Amino Acid Sequence
    • AccessionQ53EL6
    • SpeciesHuman
    • SequenceMDVENEQILNVNPADPDNLSDSLFSGDEENAGTEEIKNEINGNWISAYSI NEARINAKAKRRLRKNSSRDSGRGDSVSDSGSDALRSGLTVPTSPKGRLL DRRSRSGKGRGLPKKGGAGGKGVWGTPGQVYDVEEVDVKDPNYDDDQENC VYETVVLPLDERAFEKTLTPIIQEYFEHGDTNEVAEMLRDLNLGEMKSGV PVLAVSLALEGKASHREMTSKLLSDLCGTVMSTTDVEKSFDKLLKDLPEL ALDTPRAPQLVGQFIARAVGDGILCNTYIDSYKGTVDCVQARAALDKATV LLSMSKGGKRKDSVWGSGGGQQSVNHLVKEIDMLLKEYLLSGDISEAEHC LKELEVPHFHHELVYEAIIMVLESTGESTFKMILDLLKSLWKSSTITVDQ MKRGYERIYNEIPDINLDVPHSYSVLERFVEECFQAGIISKQLRDLCPSR GRKRFVSEGDGGRLKPESY
    • Molecular weight51 kDa
    • Amino acids1 to 469

Specifications

Our Abpromise guarantee covers the use of ab117475 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    SDS-PAGE

    HPLC

  • Purity> 90 % SDS-PAGE.
    Purity is greater than 90% as determined by RP-HPLC and SDS-PAGE.
  • FormLiquid
  • Additional notesAlthough stable 4°C for 4 weeks, should be stored desiccated below -18°C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles.
  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Please see notes section.

    pH: 8.00
    Constituents: 0.32% Tris HCl, 0.02% DTT, 0.58% Sodium chloride

General Info

  • Alternative names
    • Death up-regulated gene protein
    • Dug
    • H731
    • Ma3
    • MGC33046
    • MGC33047
    • Neoplastic transformation inhibitor
    • Neoplastic transformation inhibitor protein
    • Nuclear antigen H731
    • Nuclear antigen H731 like
    • Nuclear antigen H731 like protein
    • Nuclear antigen H731-like
    • PDCD 4
    • Pdcd4
    • PDCD4_HUMAN
    • Programmed cell death 4
    • programmed cell death 4 (neoplastic transformation inhibitor)
    • Programmed cell death protein 4
    • Protein 197/15a
    • Protein MA-3
    • Tis
    • Topoisomerase-inhibitor suppressed protein
    see all
  • FunctionInhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1, thus inhibiting events important in driving invasion, namely, MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA.
  • Tissue specificityUp-regulated in proliferative cells. Highly expressed in epithelial cells of the mammary gland. Reduced expression in lung cancer and colon carcinoma.
  • Sequence similaritiesBelongs to the PDCD4 family.
    Contains 2 MI domains.
  • DomainBinds EIF4A1 via both MI domains.
  • Post-translational
    modifications
    Polyubiquitinated, leading to its proteasomal degradation. Rapidly degraded in response to mitogens. Phosphorylation of the phosphodegron promotes interaction with BTRC and proteasomal degradation.
  • Cellular localizationNucleus. Cytoplasm. Shuttles between the nucleus and cytoplasm. Predominantly nuclear under normal growth conditions, and when phosphorylated at Ser-457. Exported from the nucleus in the absence of serum.
  • Information by UniProt

References for Recombinant Human PDCD4 protein (ab117475)

ab117475 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab117475.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"